Skip to the page

Data / Form D filings / Focal Therapeutics, Inc.

Focal Therapeutics, Inc.: Form D filings

Focal Therapeutics, Inc., a health care company in Aliso Viejo, CA, filed 3 Form D notices with the SEC between 2014 and 2017. The latest, on January 24, 2017, reports $48,880 sold of a $48,880 offering to 2 investors.

Find out what Focal Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
30 ENTERPRISE, SUITE 220, Aliso Viejo, CA, 92656
Phone
(949) 466-9248
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1618784

The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Get the first 200 rows free

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 24, 2017New notice$48,880$48,880$02Jul 27, 2016sec.gov
Mar 14, 2016New notice$5,000,000$3,826,471$1,173,52928Mar 2, 2016sec.gov
Sep 5, 2014New notice$10,060,000$7,820,000$2,240,00022Aug 13, 2013sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Steven NaberExecutive Officer
Robert BrownellDirector
Gail S. LebovicExecutive Officer, Director
Steven GexExecutive Officer, Director
Sharon D. StevensonDirector
George D. HermannExecutive Officer, Director

Other health care companies in California that filed recently

Every Form D from the week of Jan 23, 2017 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Focal Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.